Skip to main content
Quest Diagnostics

Machine Learning Analysis Using RNA Sequencing to Distinguish Neuromyelitis Optica from Multiple Sclerosis and Identify Therapeutic Candidates

Machine Learning Analysis Using RNA Sequencing to Distinguish Neuromyelitis Optica from Multiple Sclerosis and Identify Therapeutic Candidates

Authors: Wylezinski LS, Sesler CL, Shaginurova GI, Grigorenko EV, Wohlgemuth JG, Cockerill FR 3rd, Racke MK, Spurlock CF 3rd

Citation: J Mol Diagn. 2024 Mar 22:S1525-1578(24)00059-X. doi: 10.1016/j.jmoldx.2024.03.003.

Specialties: Neurology

Related content

Publication
Multiple Sclerosis Followed by Neuromyelitis Optica Spectrum Disorder: From the National Multiple Sclerosis Society Case Conference Proceedings
Publication
Pain in Multiple Sclerosis: Understanding Pathophysiology, Diagnosis, and Management
Conference Presentation
Discovery of Unique RNA Profiles Associated With Plasma Neurofilament Light Chain Measurements in Relapsing-Remitting Multiple Sclerosis and Neuromyelitis Optica

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.